Search Results - "Rubalcava, Luis Felipe"

A Latin-American Cancer Center Experience in the Treatment of Hodgkin's Lymphoma during a Drug Shortage by Rubalcava, Luis Felipe Felipe, Cesarman-Maus, Gabriela, Ramirez-Ibarguen, Ana Florencia

“…The treatment of Hodgkin's lymphoma has been characterized by a story of success with the use tried-and-true protocols. During the second half of 2019 to the…”
Get full text

Description of Patients with HIV and Multicentric Castleman's Disease at the National Institute of Cancerology- Mexico: A 9-Year Experience by Bonilla Salcedo, Andres Yesid Yesid, Castellanos Mares, Mistral, Pellon Tellez, Karen, Rivas-Vera, Silvia, Santana Sierra, Gerardo A, Rubalcava, Luis Felipe, Marin Romero, Cynthia A, Zapata Cerecedo, Linda M, Resendiz Reyes, Adriana J, Acosta Maldonado, Brenda Lizeth

“…Castleman disease is a diverse group of lymphoproliferative disorders with four variants sharing common morphological features on lymph node biopsy but having…”
Get full text

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study by Martinez-Cordero, Humberto, Fuentes Lacouture, Maria Cynthia, Spirko, Paola, Ospina-Idárraga, Juan Alejandro, Valdes Cespedes, Jaime, Pellon, Karen, Korin, Laura, Colunga-Pedraza, Perla R., Idrobo, Henry, Noboa, Andrea, Villela, Luis Mario, Robles, Arianna, Von Glasenapp, Alana, Britos, Perla N, Rodriguez, Yusaima, Rios Jiménez, Rosa Oliday, Peña, Camila, Rubalcava, Luis Felipe, Castillo, Jorge J.

“…Introduction Plasmablastic lymphoma (LP) is a highly aggressive hematologic malignancy that has been recently described. Usually appears in immunocompromised…”
Get full text

Low Prevalence of T-Cell Lymphoblastic Leukemia/Lymphoma in an Adult Hispanic Population: A Report of the Acute Leukemia Working Group (GTLA) by Rubalcava-Lara, Luis Felipe, Almanza Huante, Emmanuel, Demichelis, Roberta, Rangel-Patiño, Juan, Gomez-De Leon, Andres, De la rosa-Flores, Gerardo A, Cabrera Garcia, Alvaro, Garzon, katheryn Betsabe, Espinosa, Karla Adriana

“…Introduction: The proportion of Acute lymphoblastic T cell leukemia/lymphoma (T-ALL/LBL) in Latinamerica (LA) is about 13% [Quiroz, 2018], compared with 25% of…”
Get full text